Mitchell B Strominger, MD in Reno, NV - Medicare Ophthalmology

Mitchell B Strominger, MD is a medicare enrolled "Ophthalmology - Neuro-ophthalmology" physician in Reno, Nevada. He went to Washington University School Of Medicine and graduated in 1986 and has 38 years of diverse experience with area of expertise as Ophthalmology. He is a member of the group practice Community Care Services Llc and his current practice location is 1500 E 2nd St Ste 300, Reno, Nevada. You can reach out to his office (for appointments etc.) via phone at (775) 982-5000.

Mitchell B Strominger is licensed to practice in Nevada (license number 18310) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1528026184.

Contact Information

	Mitchell B Strominger, MD
	1500 E 2nd St Ste 300, Reno, NV 89502
	(775) 982-5000
	(775) 982-3900

Physician's Profile

Full Name	Mitchell B Strominger
Gender	Male
Speciality	Ophthalmology
Experience	38 Years
Location	1500 E 2nd St Ste 300, Reno, Nevada
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Mitchell B Strominger attended and graduated from Washington University School Of Medicine in 1986

NPI Data:

NPI Number: 1528026184
Provider Enumeration Date: 05/03/2006
Last Update Date: 10/29/2018

Medicare PECOS Information:

PECOS PAC ID: 2769517432
Enrollment ID: I20190325002411

Medical Identifiers

Medical identifiers for Mitchell B Strominger such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1528026184	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	18310 (Nevada)	Secondary
207W00000X	Ophthalmology	211857 (Massachusetts)	Secondary
207WX0109X	Ophthalmology - Neuro-ophthalmology	18310 (Nevada)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Renown Regional Medical Center	Reno, NV	Hospital
Renown South Meadows Medical Center	Reno, NV	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Community Care Services Llc	1951324318	385

News Archive

New study points to new treatments for some forms of Lou Gehrig's disease

A new study indicates that mutant Cu/Zn superoxide dismutase (SOD1) enzymes that are associated with an inherited form of Lou Gehrig's disease cause the protein to become sticky in tissues. Partial unfolding of the mutant protein can expose hydrophobic residues that may promote abnormal interactions with other proteins or membranes in the cell.

Potential cure for heart disease via cancer gene upregulation

Researchers have found that by switching on a gene that promotes the spread of cancers, they can enhance the regeneration of damaged heart muscle. The study results, published in April 2020 in the journal Nature Communication, could mark the beginning of curative therapy for heart disease.

Australian scientist finds two new animal viruses

An Australian scientist has discovered two new animal viruses, one in cattle and the other in mosquitoes - the unknown viruses were found in isolated regions of northern Australia - neither of the viruses cause disease in livestock.

FDA approves new drug for treatment of rare autoimmune disorder

The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Targeting drugs to cancer tissues is a major challenge in cancer treatment. Mesenchymal stem cells (MSCs) are known for their ability to find and target tumor cells in the body, but using MSCs for drug delivery has been tricky, because upon loading with drugs, MSCs lose their viability and migratory ability.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mitchell B Strominger allows following entities to bill medicare on his behalf.

Entity Name	Community Care Services Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1720031768 PECOS PAC ID: 1951324318 Enrollment ID: O20060111000900

News Archive

New study points to new treatments for some forms of Lou Gehrig's disease

Potential cure for heart disease via cancer gene upregulation

Australian scientist finds two new animal viruses

FDA approves new drug for treatment of rare autoimmune disorder

The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mitchell B Strominger is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mitchell B Strominger, MD 850 Harvard Way, Reno, NV 89502-2055 Ph: (775) 982-5262	Mitchell B Strominger, MD 1500 E 2nd St Ste 300, Reno, NV 89502 Ph: (775) 982-5000

News Archive

New study points to new treatments for some forms of Lou Gehrig's disease

Potential cure for heart disease via cancer gene upregulation

Australian scientist finds two new animal viruses

FDA approves new drug for treatment of rare autoimmune disorder

The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Ophthalmology Doctors in Reno, NV

David B Chaffin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5420 Kietzke Ln, Ste 103, Reno, NV 89511 Phone: 775-329-2300 Fax: 775-329-5514
Geoffrey Cecchi, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 950 Ryland St, Reno, NV 89502 Phone: 775-329-0286 Fax: 775-329-4243
Elena Geraymovych, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 610 Sierra Rose Dr, Reno, NV 89511 Phone: 775-356-7272 Fax: 775-356-2922
Shane Williamson, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 5053 S Mccarran Blvd, Reno, NV 89502 Phone: 775-853-2000
Mr. Kevin Michael Gamett, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5510 Reno Corporate Dr, Reno, NV 89511 Phone: 775-622-9078 Fax: 775-622-0696
Barbara A Irish, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 5420 Kietzke Ln, Ste 103, Reno, NV 89511 Phone: 775-329-2300 Fax: 775-329-5514
Dr. Marcus Juen Yue Ko, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5435 Reno Corporate Dr Ste 100, Reno, NV 89511 Phone: 775-322-3111 Fax: 775-322-8388

Mitchell B Strominger, MD - Medicare Ophthalmology in Reno, NV

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

New study points to new treatments for some forms of Lou Gehrig's disease

Potential cure for heart disease via cancer gene upregulation

Australian scientist finds two new animal viruses

FDA approves new drug for treatment of rare autoimmune disorder

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Medicare Reassignments

New study points to new treatments for some forms of Lou Gehrig's disease

Potential cure for heart disease via cancer gene upregulation

Australian scientist finds two new animal viruses

FDA approves new drug for treatment of rare autoimmune disorder

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

New study points to new treatments for some forms of Lou Gehrig's disease

Potential cure for heart disease via cancer gene upregulation

Australian scientist finds two new animal viruses

FDA approves new drug for treatment of rare autoimmune disorder

Researchers use new method to deliver anti-cancer drug to suppress tumor growth

Ophthalmology Doctors in Reno, NV